29Oct 2023
Recent advances in epicutaneous immunotherapy and potential applications in food allergy

Recent advances in epicutaneous immunotherapy and potential applications in food allergy

Epicutaneous immunotherapy (EPIT) shows promise in treating food allergies by leveraging the skin's immunological properties. It minimizes systemic allergen exposure and is suitable for potentially life-threatening food allergies. Various approaches are being explored, including allergen-coated microneedles and occlusive epicutaneous systems. Viaskin, an occlusive patch with native allergen extracts, is a clinically advanced EPIT method. Preclinical studies have shown that Viaskin induces long-lasting T-regulatory cells with broad suppressive effects. Clinical trials in younger patients demonstrate its efficacy and safety, offering a non-invasive therapy without daily activity restrictions. EPIT presents an exciting avenue for improving allergic disorder treatments in the near future.

  • #dermatology

Like

Save

Share